James Hassard
Corporate Officer/Principal bei CRINETICS PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
James Hassard is currently the Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. He previously held the position of Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. from 2020 to 2021.
Prior to that, he was the Vice President-Marketing at Medivation LLC (California) and the General Manager at Amgen BIO Farmaceutica Ltda.
From 2016 to 2020, he served as the Senior Vice President-Marketing & Market Access at Coherus BioSciences, Inc. Mr. Hassard holds an MBA from Nova Southeastern University, Inc. and an undergraduate degree from the University of Toronto.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 29 259 ( 0,04% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von James Hassard
| Unternehmen | Position | Beginn |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2022 |
Ehemalige bekannte Positionen von James Hassard
| Unternehmen | Position | Ende |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23.08.2021 |
| COHERUS BIOSCIENCES, INC. | Vertrieb & Marketing | 01.01.2020 |
| Amgen BIO Farmaceutica Ltda | Corporate Officer/Principal | - |
| MEDIVATION INC | Vertrieb & Marketing | - |
Ausbildung von James Hassard
| University of Toronto | Undergraduate Degree |
| Nova Southeastern University, Inc. | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| COHERUS BIOSCIENCES, INC. | Health Technology |
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
| Amgen BIO Farmaceutica Ltda |
